CLINICAL FEATURES AND OUTCOMES OF HBEAG plus CHRONIC HEPATITIS B (CHB) IN PREGNANT WOMEN

被引：0
|
作者：
Pan, Calvin [1 ]
Han, Guo Rong [2 ]
Cao, Min Kai [3 ]
Zhao, Wei [2 ]
Jiang, Hong Xiu [2 ]
机构：
[1] Elmhurst Hosp, Mt Sinai Serv, Mt Sinai Sch Med, Flushing, NY USA
[2] Southeast Univ, Affiliated Hosp 2, Nanjing, Peoples R China
[3] Southeast Univ, Sch Med, Nanjing, Peoples R China
来源：
HEPATOLOGY | 2010年 / 52卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1426
引用
收藏
页码：1006A / 1006A
页数：1
相关论文
共 50 条
  • [1] A PROSPECTIVE OPEN-LABEL STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF TELBUVIDINE (LTD) IN HBEAG plus CHRONIC HEPATITIS B (CHB) PREGNANT WOMEN
    Pan, Calvin
    Han, Guo Rang
    Zhao, Wei
    Jiang, Hong Xiu
    Cao, Min Kai
    HEPATOLOGY, 2010, 52 (04) : 500A - 501A
  • [2] EFFICACY AND SAFETY OF LAMIVUDINE USE IN HIGHLY VIREMIC MOTHERS WITH HBEAG plus CHRONIC HEPATITIS B (CHB) IN CLINICAL PRACTICE
    Pan, Calvin
    Han, Guo Rong
    Jiang, Hong Xiu
    Ge, Chun Yan
    Xu, Chuan Lu
    Zhao, Wei
    HEPATOLOGY, 2011, 54 : 881A - 882A
  • [3] EFFICACY AND SAFETY OF TELBIVUDINE USE IN HIGHLY VIREMIC MOTHERS WITH HBEAG plus CHRONIC HEPATITIS B (CHB) IN CLINICAL PRACTICE
    Han, G.
    Jiang, H.
    Zhao, W.
    Ge, C.
    Xu, C.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S202 - S202
  • [4] HBeAg profile in patients with chronic HBeAg plus hepatitis B (CHB) treated with emtricitabine (FTC) for 1 year.
    Gish, RG
    Wright, T
    Wang, C
    Corey, L
    Leung, N
    Sykes, A
    Mondou, E
    Fang, L
    Rousseau, FS
    HEPATOLOGY, 2001, 34 (04) : 316A - 316A
  • [5] Durable HBeAg and HBsAg seroconversions after lamivudine for chronic hepatitis B (CHB)
    Schiff, E
    Cianciara, J
    Karayalcin, S
    Kowdley, K
    Woessners, M
    McMullens, S
    Pearce, M
    Browns, N
    JOURNAL OF HEPATOLOGY, 2000, 32 : 99 - 99
  • [6] Different interventional criteria for chronic hepatitis B pregnant women with HBeAg(+) or HBeAg(-) Epidemiological data from Shaanxi, China
    Chen, Tianyan
    Wang, Jing
    Qiu, Hongtao
    Yu, Qiang
    Yan, Taotao
    Qi, Caijing
    Cao, Furong
    Tian, Zhen
    Guo, Dandan
    Yao, Naijuan
    Yang, Yuan
    He, Yingli
    Zhao, Yingren
    Liu, Jinfeng
    MEDICINE, 2018, 97 (27)
  • [7] Outcomes of Oral Antiviral Treatment for Chronic Hepatitis B (CHB) in Routine Clinical Practice
    Nguyen, Mindie H.
    Trinh, Huy N.
    Nguyen, Huy A.
    Nguyen, Khanh K.
    Garcia, Ruel T.
    Tang, Hong
    Levitt, Brian S.
    Juday, Timothy
    GASTROENTEROLOGY, 2012, 142 (05) : S953 - S954
  • [8] Clinical outcomes of tenofovir disoproxil fumarate (TDF) treatment versus no treatment for pregnant women with active chronic hepatitis B (CHB) and elevated alanine aminotransaminase (ALT)
    Yi, Wei
    Pan, Calvin Q.
    Liu, Min
    Cai, Haodong
    HEPATOLOGY, 2014, 60 : 1094A - 1094A
  • [9] No Detectable Resistance to Tenofovir Disoproxil Fumarate (TDF) in HBeAg plus and HBeAg- Patients with Chronic Hepatitis B (CHB) After Eight Years of Treatment
    Corsa, Amoreena C.
    Liu, Yang
    Flaherty, John F.
    Marcellin, Patrick
    Miller, Michael D.
    Kitrinos, Kathryn M.
    HEPATOLOGY, 2014, 60 : 1020A - 1020A
  • [10] Durability of HBeAg seroconversion following adefovir dipivoxil treatment for chronic hepatitis B (CHB)
    Chang, T. T.
    Shiffman, M. L.
    Tong, M.
    Liaw, Y. F.
    Komolmit, P.
    Sorbel, J.
    Arterburn, S.
    Mondou, E.
    Chuck, S.
    Marcellin, P.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S93 - S93
12345